Atriva Therapeutics
Latest round
- Series A
Last raised
- Jan 2019
Total raised
- Undisclosed
Investors
- 3
About Atriva Therapeutics
Founded in 2015 and based in Tübingen, Germany, Atriva Therapeutics GmbH is a pharmaceutical company that develops novel therapeutics for the treatment of pandemic influenza.
Who invested in Atriva Therapeutics
3 investors across 3 rounds
See all investors in Atriva Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atriva Therapeutics
Who invested in Atriva Therapeutics?
Atriva Therapeutics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atriva Therapeutics raised?
Atriva Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Atriva Therapeutics last raise money?
Atriva Therapeutics's most recent round on record is a Series A, in Jan 2019.
What does Atriva Therapeutics do?
Founded in 2015 and based in Tübingen, Germany, Atriva Therapeutics GmbH is a pharmaceutical company that develops novel therapeutics for the treatment of pandemic influenza.
Where is Atriva Therapeutics headquartered?
Atriva Therapeutics is headquartered in Tubingen, Germany.
Which VCs invest in companies like Atriva Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Atriva Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Atriva Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.